Skip to Main Content

Paper Details

Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia.
JCI Insight
2
2023
Author NameAffiliation
Friedrich St??lzelMedical Clinic and Polyclinic I, University Hospital Dresden, Technical University of Dresden
Leo RuhnkeMedical Clinic and Polyclinic I, University Hospital Dresden, Technical University of Dresden
Heidi AltmannMedical Clinic and Polyclinic I, University Hospital Dresden, Technical University of Dresden
Christoph R??lligMedical Clinic and Polyclinic I, University Hospital Dresden, Technical University of Dresden
Torsten Haferlach
Steven J AltschulerDepartment of Pharmaceutical Chemistry, School of Pharmacy, University of California san francisco
Lani F WuDepartment of Pharmaceutical Chemistry, School of Pharmacy, University of California san francisco
  • 1 - 7

Datasets